SIM
NAGE

Spark Investment Management’s Niagen Bioscience NAGE Stock Holding History

Spark Investment Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,200
Closed -$70K – 524
2019
Q2 		$70K Sell
15,200
-3,587
-19% -$15.3K ﹤0.01% 521
2019
Q1 		$78K Buy
+18,787
New +$67.7K ﹤0.01% 593
2016
Q4 		– Sell
-135,900
Closed -$404K – 895
2016
Q3 		$404K Buy
135,900
+26,500
+24% +$97.3K 0.03% 526
2016
Q2 		$452K Buy
+109,400
New +$518K 0.04% 482

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Spark Investment Management's NAGE Position: Q3 2019 in Review

Spark Investment Management sold out of Niagen Bioscience (NAGE) in Q3 2019, closing a stake of 15,200 shares — an estimated $70K sold.

Spark Investment Management first reported a position in NAGE in Q2 2016 and held it in 4 quarters. The position peaked at $452K in Q2 2016. 60 funds tracked by Wall St. Rank hold NAGE as of Q3 2019.

  • Spark Investment Management reported no remaining Niagen Bioscience position as of Q3 2019 after selling out during the quarter.
  • Spark Investment Management sold 15,200 Niagen Bioscience shares in Q3 2019, an estimated $70K.
  • Spark Investment Management first reported a position in Niagen Bioscience in Q2 2016 and held it in 4 quarters.
  • Spark Investment Management's Niagen Bioscience position peaked at $452K in Q2 2016.
  • 60 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.